Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG for Nerve Repair in Phalloplasty
NCT05897086Phase 3Enrolling by invitation
- Sponsor
- Vanderbilt University Medical Center
- Start
- Aug 2023
- Primary completion
- Dec 2028
- Modality
- Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
- Countries
- 1
01
Overview
A Phase 3 trial of polyethylene glycol 3350 in gender dysphoria (GD), sponsored by Vanderbilt University Medical Center. Started Aug 2023; status: enrolling by invitation.
02
Drugs
polyethylene glycol 3350
03
Conditions
gender dysphoria (GD)
Beyond the preview
Go deeper on NCT05897086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05897086.